Navigation Links
Poniard Completes Patient Enrollment Target in Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
Date:3/25/2009

SOUTH SAN FRANCISCO, Calif., March 25 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that it has reached its enrollment target of 400 patients in the SPEAR (Study of Picoplatin Efficacy After Relapse) trial. This global, pivotal Phase 3 trial is evaluating the efficacy and safety of picoplatin in patients with recurrent small cell lung cancer (SCLC) who have failed prior platinum-containing first-line chemotherapy or who have progressed within six months of first-line therapy. Patients have been enrolled at more than 100 clinical trial sites in 16 countries in Europe, South America and Asia.

"Completion of patient enrollment in our pivotal Phase 3 SPEAR trial represents an important milestone for Poniard. We accomplished this ahead of internal projections, which allows us to keep on schedule to complete the clinical data analysis and initiate the filing of a rolling New Drug Application with the U.S. Food and Drug Administration for picoplatin in SCLC this year," said Jerry McMahon, Ph.D., chairman and chief executive officer of Poniard. "We believe that picoplatin will provide a survival benefit for SCLC patients who have failed platinum-based therapy consistent with survival data we have previously generated in two independent Phase 2 trials. We also expect the data will show that picoplatin overcomes resistance in patients treated with current platinum-based chemotherapies. This would be a new use for a platinum chemotherapy agent. We are also continuing to analyze additional clinical data from our picoplatin Phase 2 trials in first-line treatment for metastatic colorectal and prostate cancers and will report on them later this year."

"We are pleased to have completed trial enrollment ahead of schedule," said Robert De Jager, M.D.
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, 2015 ... market for flow cytometry is experiencing a rise ... is the demand in underdeveloped nations to quantitate ... patients. Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... Sullivan, Analysis of the Global Flow Cytometry Market ...
(Date:8/31/2015)... -- The departments of Drug and Alcohol Programs (DDAP) and ... to raise awareness for International Overdose Awareness Day to ... and help more Pennsylvanians with substance use ... Building Bridges to Recovery initiative. ... a disease that is fully treatable, if given the ...
(Date:8/31/2015)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest ... Chairman & CEO, and Sean Whelan , CFO, will ... Hagerman and Mr. Whelan are scheduled to participate in the ... on Wednesday, September 9, 2015 at 1:45 PM ET. ... to participate in the Robert W. Baird 2015 Healthcare Conference ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... Life Length, the world,s leading telomere testing and services ... have joined its Scientific Advisory Board ("SAB"). ... delighted to welcome these world-renowned telomere and telomerase experts ... global leadership.  Dr Chang is especially well known for ...
... Colo., March 6, 2012   Heska Corporation (NASDAQ: ... veterinary diagnostic and other specialty veterinary products , today ... of best practices research, tools and metrics for patent ... again ranked Heska,s Science Strength in the top 50 ...
Cached Medicine Technology:Drs Sandy Chang and Kathleen Collins Join LIFE LENGTH®'s Scientific Advisory Board 2The Patent Board Ranks Heska's Science Strength in Biotechnology Industry Top 50 2The Patent Board Ranks Heska's Science Strength in Biotechnology Industry Top 50 3
(Date:8/31/2015)... Florida (PRWEB) , ... August 31, 2015 , ... ... health insurance, announced today their new “ InstantQuote ” tool, which summarizes all ... and easy-to-understand format. The technology tool is designed to help India Network members ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s ... , Starting September 1st they are offering pre and postnatal fitness ... "Healthy Body, Healthy Baby." , More information can be found at 248-601-6683. , ...
(Date:8/31/2015)... ... 31, 2015 , ... The Sundance Film Festival award winning documentary “Alive Inside” ... Inside” shadows a social worker who advocates for the use of music therapy for ... music to residents in health care centers who may have lost a spark in ...
(Date:8/31/2015)... NJ (PRWEB) , ... August 31, 2015 , ... Since ... quality, patient-oriented dental care. From the moment a patient arrives at the office, ... Steven Tuckman will work with each and every patient to create a complete dental ...
(Date:8/31/2015)... N.J. (PRWEB) , ... August 31, 2015 , ... ... participants—physicians, drug makers, diagnostic services, and others—to hold down costs? , In a ... chief executive officer of HealthReveal, presents the concept of “clinical efficacy,” which would ...
Breaking Medicine News(10 mins):Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3
... blood carry newly identified proteins that could be screened to ... at the Duke Cancer Institute. Building on current technologies ... was able to characterize these cells in a new way, ... move to other locations in the body. The circulating ...
... Leader of the Stem Cell and Developmental Biology at ... Dr Wa Xian at A*STAR,s Institute of Medical Biology ... School, the Brigham and Women,s Hospital in Boston, and ... finding that Barrett,s esophagus[1] work, published online in the ...
... Bdellovibrio against Salmonella in ... reduced the numbers of Salmonella bacteria and, importantly, ... The research was funded by the Biotechnology and Biological ... at The University of Nottingham, with Dr Robert Atterbury and ...
... -- The last quarter century has seen a such an explosion ... now struggle with the disease, a new British-American study reveals. ... diabetes has more than doubled, jumping from 153 million in 1980 ... diabetes in the United States is rising twice as fast as ...
... -- Lifestyle changes such as losing weight, drinking less alcohol ... in breast cancer cases across an entire population, according to ... risk factors. Although such models are often used to ... that women can,t change, such as a family history of ...
... FRIDAY, June 24 (HealthDay News) -- An exhausting emergency rescue ... lifeguard,s ability to carry out lifesaving CPR, according to a ... in doing cardiopulmonary resuscitation than were emergency medical personnel, the ... had 26 male and 14 female lifeguards perform CPR alone ...
Cached Medicine News:Health News:Duke team finds new clues to how cancer spreads 2Health News:Scientists identify a novel mechanism for evolution of highly aggressive cancers 2Health News:Scientists identify a novel mechanism for evolution of highly aggressive cancers 3Health News:Living antibiotic effective against Salmonella 2Health News:Diabetes on Upswing Worldwide 2Health News:Diabetes on Upswing Worldwide 3Health News:Lifestyle Changes Might Alter Breast Cancer Rates 2Health News:Exhausting Surf Rescues Don't Affect Lifeguards' CPR Skills 2
The KM-500's unique viewing and alignment window lets you observe the targeted eye from any distance. Two rechargeable batteries provide continuous uninterrupted use. Each battery provides 60 minutes...
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
... Provides quick freezing and quick ... gas system - cleans the ... Lightweight probe tips have high ... Retinal Detachment, Glaucoma and Intra-vitreal ...
... instant defrosting by reversible flow of gas ... cycle automatically. Lightweight probe tips have high ... I/A. The surgeon can select either of ... Surgeon can have a selection of Irrigation, ...
Medicine Products: